title: The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment.
abstract: Flunarizine is a class IV calcium channel blocker which increases oxygen delivery to hypoxic regions in solid tumours, exerting a radiosensitising effect in vivo in animal tumour models. Precisely how the drug improves oxygenation is not well understood. We hypothesised that metabolic conditions present within solid tumours reduce red blood cell (RBC) deformability and that flunarizine exerts its in vivo effect by preventing this loss of RBC deformability. A microrheometer was used to compare the viscosity of rat and human RBC suspensions in conditions of hypoxia (pO2 < 10 mmHg), acidic environment (pH 6.8), and elevated lactate concentration (lactate 5 mMol l-1), without or with flunarizine at concentrations of 5, 10, and 50 mg l-1. The effects of flunarizine on RBC density and morphology were also recorded. Hypoxia, low pH, and lactate exposure together increased both human and rat RBC suspension viscosity. Flunarizine at concentrations of 5 and 10 mg l-1 prevented the increases in viscosity. The drug caused dose-dependent shifts toward lower cell density while inducing a characteristic cupped shape (stomatcytic morphology), suggesting a mechanism involving calmodulin inhibition. The results support the hypothesis that flunarizine improves tumour blood flow and oxygenation by enhancing flow properties of RBC's in solid tumours.
authors: Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710.
authors: B D
authors: BD
authors: Kavanagh
authors: B E
authors: BE
authors: Coffey
authors: D
authors: D
authors: Needham
authors: R M
authors: RM
authors: Hochmuth
authors: M W
authors: MW
authors: Dewhirst
mesh_terms: D000818:Animals; D001809:Blood Viscosity / Q000187:drug effects*; D002452:Cell Count; D015687:Cell Hypoxia / Q000502:physiology*; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004907:Erythrocyte Deformability / Q000187:drug effects; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects*; D005444:Flunarizine / Q000494:pharmacology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D007773:Lactates / Q000494:pharmacology*; D019344:Lactic Acid; D010100:Oxygen / Q000097:blood; D051381:Rats; D011916:Rats, Inbred F344; D012212:Rheology
chemical_list: D007773:Lactates; D019344:Lactic Acid; D005444:Flunarizine; D010100:Oxygen